|
|
Tetsuro Takeda, Tammie McQuistan, Robert A. Orlando, Marilyn G. Farquhar
J Clin Invest. 2001;
108(2):289
doi:10.1172/JCI12539
Abstract |
Full text
| PDF

P
odocalyxin (PC), the major sialoprotein of glomerular epithelial cells (GECs), helps maintain the characteristic architecture of the foot processes and the patency of the filtration slits. PC associates with actin via ezrin, a member of the ERM family of cytoskeletal linker proteins. Here we show that PC is linked to ezrin and the actin cytoskeleton via Na+/H+-exchanger regulatory factor 2 (NHERF2), a scaffold protein containing two PDZ (PSD-95/Dlg/ZO-1) domains and an ERM-binding region. The cytoplasmic tail of PC contains a C-terminal PDZ-binding motif (DTHL) that binds to the second PDZ domain of NHERF2 in yeast two-hybrid and in vitro pull-down assays. By immunocytochemistry NHERF2 colocalizes with PC and ezrin along the apical domain of the GEC plasma membrane. NHERF2 and ezrin form a multimeric complex with PC, as they coimmunoprecipitate with PC. The PC/NHERF2/ezrin complex interacts with the actin cytoskeleton, and this interaction is disrupted in GECs from puromycin aminonucleoside–, protamine sulfate–, or sialidase-treated rats, which show a dramatic loss of foot processes, comparable to that seen in the nephrotic syndrome. Thus NHERF2 appears to function as a scaffold protein linking PC to ezrin and the actin cytoskeleton. PC/NHERF2/ezrin/actin interactions are disrupted in pathologic conditions associated with changes in GEC foot processes, indicating their importance for maintaining the unique organization of this epithelium.J. Clin. Invest. 108:289–301 (2001). DOI:10.1172/JCI200112539.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(21)
| Title and authors |
Publication |
Year |
Cell Biology and Pathology of Podocytes
Anna Greka, Peter Mundel
|
Annu. Rev. Physiol.
|
2012 |
A hierarchy of signals regulates entry of membrane proteins into the ciliary membrane domain in epithelial cells
S. S. Francis, J. Sfakianos, B. Lo, I. Mellman
|
The Journal of Cell Biology
|
2011 |
Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane
S. Goldberg, S. J. Harvey, J. Cunningham, K. Tryggvason, J. H. Miner
|
Nephrology Dialysis Transplantation
|
2009 |
Role of podocytes in lupus nephritis
S. Trivedi, M. Zeier, J. Reiser
|
Nephrology Dialysis Transplantation
|
2009 |
Proteinuria: an enzymatic disease of the podocyte?
Peter Mundel, Jochen Reiser
|
Kidney Int
|
2009 |
Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome
F. Duner, J. Patrakka, Z. Xiao, J. Larsson, A. Vlamis-Gardikas, E. Pettersson, K. Tryggvason, K. Hultenby, A. Wernerson
|
Nephrology Dialysis Transplantation
|
2008 |
Dual effects of RAS blockade on blood pressure and podocyte function
Jochen Reiser, Peter Mundel
|
Current Science Inc
|
2007 |
Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine
Belinda Galeano, Riko Klootwijk, Irini Manoli, MaoSen Sun, Carla Ciccone, Daniel Darvish, Matthew F. Starost, Patricia M. Zerfas, Victoria J. Hoffmann, Shelley Hoogstraten-Miller, Donna M. Krasnewich, William A. Gahl, Marjan Huizing
|
J. Clin. Invest.
|
2007 |
Sizing up sialic acid in glomerular disease
Susan E. Quaggin
|
J. Clin. Invest.
|
2007 |
The role of podocytes in proteinuria
KATSUHIKO ASANUMA, ETSUKO YANAGIDA-ASANUMA, MIYUKI TAKAGI, FUMIKO KODAMA, YASUHIKO TOMINO
|
Nephrology
|
2007 |
|